Clinical Trials Browser

Phase 1/2 × INDUSTRY × Non-Small Cell Lung Cancer Metastatic × Clear all

NCT03732274 2025-04-10

Phase 1b/2a, Open-label Study of Vactosertib in Combination With Durvalumab in Advanced NSCLC

Phase 1/2 Completed

Non-Small Cell Lung Cancer Metastatic